We believe this site might serve you best:

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

HeLaScribe® Nuclear Extract, in vitro Transcription Grade

Cell-Free Extract for in vitro Transcription of Eukaryotic Genes

  • Component of the HeLaScribe® Nuclear Extract in vitro Transcription System
  • Source of transcription factors, DNA-binding proteins and RNA processing components

Size

Catalog number selected: E3091

$ 315.00 Your price: Log In

HeLaScribe® Nuclear Extract, in vitro Transcription Grade
40 reactions
$ 315.00
Your price: Log In
Change Configuration

HeLaScribe® Nuclear Extract, in vitro Transcription Grade, derived from HeLa cell nuclei, provides a cell-free system for in vitro transcription of eukaryotic genes. The HeLaScribe® Nuclear Extract Positive Control DNA is a component of the HeLaScribe® Nuclear Extract in vitro Transcription System that is available separately.

Specifications

You are viewing: E3091 Change Configuration

What's in the box?

Item Part # Size

HeLaScribe® Nuclear Extract Transcription Grade

E309A 2 × 20 reactions

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
View more results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

AA

 

Specifications

You are viewing: E3092 Change Configuration

What's in the box?

Item Part # Size

HeLaScribe® Nuclear Extract Transcription Grade

E309A 8 × 20 reactions

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
View more results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

AA

 

Choose your country

Americas

Brazil
Canada
United States

Pacific Asia

Australia
India
Japan
Korea, Republic of
Singapore

Europe

Austria
Belgium
Denmark
Estonia
Finland
France
Germany
Iceland
Italy
Luxembourg
Netherlands
Norway
Poland
Spain
Sweden
Switzerland
United Kingdom